EU regulation of the life sciences inquiry
Inquiry by the Science and Technology Committee (Commons), 21 January 2016 to 3 May 2017. Its page on the Parliament website.
Reports and responses
- 1st Report - EU regulation of the life sciences (11 June 2016)
Evidence sessions
- 22 March 2016: Stuart Pritchard, EU Affairs Manager, Wellcome Trust, Dr Keith Ison, and Professor Berne Ferry, representing the Shelford Group; Dr Jacqueline Barry, Director of Regulatory Affairs, Cell and Gene Therapy Catapult, Paul Browning, Head of Regulatory Affairs, Brightwake Ltd, Darren Budd, Commercial Director - UK and Ireland, BASF, and Steve Bates, Chief Executive Officer, BioIndustry Association (at 3.00pm); Professor Roger Lemon, representing the Academy of Medical Sciences, and Sir John Skehel, Vice-President and Biological Secretary, The Royal Society (at 3.45pm).
- 19 April 2016: Emma Greenwood, Head of Policy Development, Cancer Research UK; Dr Ian Hudson, Chief Executive, Jonathan Mogford, Director of Policy, and John Wilkinson, Director of Devices, Medicines and Healthcare products Regulatory Agency; George Freeman MP, Parliamentary Under-Secretary of State, Department for Business, Innovation and Skills and the Department of Health.